BioStem Technologies, Inc. (BSEM)

OTCMKTS · Delayed Price · Currency is USD
5.50
-0.28 (-4.89%)
Mar 5, 2026, 3:58 PM EST
Market Cap92.28M -62.8%
Revenue (ttm)292.21M +399.0%
Net Income20.20M +27.4%
EPS0.85 +4.3%
Shares Out16.81M
PE Ratio6.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,657
Average Volume92,117
Open5.85
Previous Close5.78
Day's Range5.50 - 6.05
52-Week Range3.09 - 15.74
Beta-0.00
RSI47.70
Earnings DateApr 13, 2026

About BioStem Technologies

BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human conne... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 33
Stock Exchange OTCMKTS
Ticker Symbol BSEM
Full Company Profile

Financial Performance

Financial Statements